| __timestamp | AstraZeneca PLC | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 26095000000 | 75334000 |
| Thursday, January 1, 2015 | 24708000000 | 135057000 |
| Friday, January 1, 2016 | 23002000000 | 146691000 |
| Sunday, January 1, 2017 | 22465000000 | 316613000 |
| Monday, January 1, 2018 | 22090000000 | 151862000 |
| Tuesday, January 1, 2019 | 24384000000 | 195992000 |
| Wednesday, January 1, 2020 | 26617000000 | 267594000 |
| Friday, January 1, 2021 | 37417000000 | 443310000 |
| Saturday, January 1, 2022 | 44351000000 | 660116000 |
| Sunday, January 1, 2023 | 45811000000 | 829253000 |
| Monday, January 1, 2024 | 54073000000 | 1015324000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, AstraZeneca PLC and Halozyme Therapeutics, Inc. have carved distinct paths. Over the past decade, AstraZeneca has consistently outpaced Halozyme in annual revenue. From 2014 to 2023, AstraZeneca's revenue surged by approximately 76%, reaching a peak in 2023. In contrast, Halozyme's revenue, while growing, remains a fraction of AstraZeneca's, with a notable increase of over 1,000% during the same period. This stark contrast highlights AstraZeneca's dominant market position, driven by its expansive product portfolio and global reach. Meanwhile, Halozyme's growth trajectory, though smaller in scale, underscores its potential in niche markets. As the pharmaceutical industry evolves, these revenue trends offer a glimpse into the strategic directions and market dynamics shaping these two companies.
Breaking Down Revenue Trends: AbbVie Inc. vs AstraZeneca PLC
AstraZeneca PLC or Alkermes plc: Who Leads in Yearly Revenue?
Revenue Insights: AstraZeneca PLC and Perrigo Company plc Performance Compared
Breaking Down Revenue Trends: AstraZeneca PLC vs ACADIA Pharmaceuticals Inc.
AstraZeneca PLC or Dynavax Technologies Corporation: Who Leads in Yearly Revenue?
Novartis AG vs Halozyme Therapeutics, Inc.: Annual Revenue Growth Compared
Regeneron Pharmaceuticals, Inc. and Halozyme Therapeutics, Inc.: A Comprehensive Revenue Analysis
United Therapeutics Corporation and Halozyme Therapeutics, Inc.: A Comprehensive Revenue Analysis
Who Generates More Revenue? Catalent, Inc. or Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. and ADMA Biologics, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Halozyme Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated Performance Compared
Revenue Showdown: Halozyme Therapeutics, Inc. vs Geron Corporation